［1］ MIASKOWSKI C,BARSEVICK A,BERGER A,et al.Advancing symptom science through symptom cluster research:expert panel proceedings and recommendations［J］.Journal of the National Cancer Institute,2017,109(4):w253.
[2] KWEKKEBOOM KL.Cancer symptom cluster management［J］.Seminars in Oncology Nursing,2016,32(4):373-382.
[3] MCFARLAND DC,JUTAGIR DR,MILLER AH,et al.Tumor mutation burden and depression in lung cancer:association with inflammation［J］.Journal of the National Comprehensive Cancer Network,2020,18(4):434-442.
[4] HIMBERT C,OSE J,LIN T,et al.Inflammation-and angiogenesis-related biomarkers are correlated with cancer-related fatigue in colorectal cancer patients:Results from the ColoCare Study［J］.European Journal of Cancer Care,2019,28(4):e13055.
[5] JEON MS,DHILLON HM,AGAR MR.Sleep disturbance of adults with a brain tumor and their family caregivers:a systematic review［J］.Neuro-Oncology,2017,19(8):1035-1046.
[6] MCFARLAND DC,BREITBART W,MILLER AH,et al.Depression and inflammation in patients with lung cancer:a comparative analysis of acute phase reactant inflammatory markers［J］.Psychosomatics,2020,61(5):527-537.
[7] DINARELLO CA.Proinflammatory cytokines［J］.Chest,2000,118(2):503-508.
[8] WALDMANN TA.Cytokines in cancer immunotherapy［J］.Cold Spring Harbor Perspectives in Biology,2018,10(12):a28472.
[9] PADOAN A,PLEBANI M,BASSO D.Inflammation and pancreatic cancer:focus on metabolism,cytokines,and immunity［J］.International Journal of Molecular Sciences,2019,20(3):676.
[10] LI L,YU R,CAI T,et al.Effects of immune cells and cytokines on inflammation and immunosuppression in the tumor microenvironment［J］.International Immunopharmacology,2020,88:106939.
[11] WATKINS LR,WIERTELAK EP,GOEHLER LE,et al.Neurocircuitry of illness-induced hyperalgesia［J］.Brain Research,1994,639(2):283-299.
[12] ROMEO HE,TIO DL,RAHMAN SU,et al.The glossopharyngeal nerve as a novel pathway in immune-to-brain communication:relevance to neuroimmune surveillance of the oral cavity［J］.Journal of Neuroimmunology,2001,115(1):91-100.
[13] SERGEEVA M,RECH J,SCHETT G,et al.Response to peripheral immune stimulation within the brain:magnetic resonance imaging perspective of treatment success［J］.Arthritis Research & Therapy,2015,17(1):268.
[14] LOGSDON AF,ERICKSON MA,RHEA EM,et al.Gut reactions:How the blood-brain barrier connects the microbiome and the brain［J］.Experimental Biology and Medicine (Maywood,N.J.),2018,243(2):159-165.
[15] LEFF-GELMAN P,MANCILLA-HERRERA I,FLORES-RAMOS M,et al.The immune system and the role of inflammation in perinatal depression［J］.Neuroscience Bulletin,2016,32(4):398-420.
[16] PITMAN A,SULEMAN S,HYDE N,et al.Depression and anxiety in patients with cancer［J］.BMJ,2018,361:k1415.
[17] LUTGENDORF SK,ANDERSEN BL.Biobehavioral approaches to cancer progression and survival:Mechanisms and interventions［J］.American Psychologist,2015,70(2):186-197.
[18] SATIN JR,LINDEN W,PHILLIPS MJ.Depression as a predictor of disease progression and mortality in cancer patients［J］.Cancer,2009,115(22):5349-5361.
[19] SMITH KJ,AU B,OLLIS L,et al.The association between C-reactive protein,Interleukin-6 and depression among older adults in the community:A systematic review and meta-analysis［J］.Experimental Gerontology,2018,102:109-132.
[20] LAMERS F,MILANESCHI Y,SMIT JH,et al.Longitudinal association between depression and inflammatory markers:results from the Netherlands Study of Depression and Anxiety［J］.Biol Psychiatry,2019,85(10):829-837.
[21] SMITH RS.The macrophage theory of depression［J］.Med Hypotheses,1991,35(4):298-306.
[22] WALKER WH,BORNIGER JC.Molecular mechanisms of cancer-induced sleep disruption［J］.International Journal of Molecular Sciences,2019,20(11):2780.
[23] DENICOFF KD,RUBINOW DR,PAPA MZ,et al.The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells［J］.Ann Intern Med,1987,107(3):293-300.
[24] SIMONETTI A,LIJFFIJT M,SWANN AC.The neurobiology of mixed states［J］.Psychiatric Clinics of North America,2020,43(1):139-151.
[25] BARRETO FS,CHAVES FILHO AJM,DE ARAUJO MCCR,et al.Tryptophan catabolites along the indoleamine 2,3-dioxygenase pathway as a biological link between depression and cancer［J］.Behavioural Pharmacology,2018,29(2 and 3):165-180.
[26] MENG L,BAI X,ZHENG Y,et al.Altered expression of norepinephrine transporter participate in hypertension and depression through regulated TNF-α and IL-6［J］.Clinical and Experimental Hypertension,2020,42(2):181-189.
[27] FELGER JC,TREADWAY MT.Inflammation effects on motivation and motor activity:role of dopamine［J］.Neuropsychopharmacology,2017,42(1):216-241.
[28] DUMAN RS,SANACORA G,KRYSTAL JH.Altered connectivity in depression:GABA and glutamate neurotransmitter deficits and reversal by novel treatments［J］.Neuron (Cambridge,Mass.),2019,102(1):75-90.
[29] NETTIS MA,PARIANTE CM.Is there neuroinflammation in depression?Understanding the link between the brain and the peripheral immune system in depression［J］.International Review of Neurobiology,2020,152:23-40.
[30] KOHLER O,KROGH J,MORS O,et al.Inflammation in depression and the potential for anti-inflammatory treatment［J］.Curr Neuropharmacol,2016,14(7):732-742.
[31] RUS GZ,DOS SANTOS MAB,STRASSI AP,et al.Pathophysiological mechanisms involved in the relationship between diabetes and major depressive disorder［J］.Life Sciences,2017,183:78-82.
[32] FERRARI AJ,SOMERVILLE AJ,BAXTER AJ,et al.Global variation in the prevalence and incidence of major depressive disorder:a systematic review of the epidemiological literature［J］.Psychol Med,2013,43(3):471-481.
[33] HERNANDEZ NV,RAMIREZ JL,KHETANI SA,et al.Depression severity is associated with increased inflammation in veterans with peripheral artery disease［J］.Vascular Medicine,2018,23(5):445-453.
[34] KHLER CA,FREITAS TH,MAES M,et al.Peripheral cytokine and chemokine alterations in depression:a meta-analysis of 82 studies［J］.Acta Psychiatrica Scandinavica,2017,135(5):373-387.
[35] MA L,DEMIN KA,KOLESNIKOVA TO,et al.Animal inflammation-based models of depression and their application to drug discovery［J］.Expert Opin Drug Discov,2017,12(10):995-1009.
[36] MULLER N,SCHWARZ MJ,DEHNING S,et al.The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression:results of a double-blind,randomized,placebo controlled,add-on pilot study to reboxetine［J］.Mol Psychiatry,2006,11(7):680-684.
[37] TYRING S,GOTTLIEB A,PAPP K,et al.Etanercept and clinical outcomes,fatigue,and depression in psoriasis:double-blind placebo-controlled randomised phase III trial［J］.Lancet,2006,367(9504):29-35.
[38] HANNESTAD J,DELLAGIOIA N,BLOCH M.The effect of antidepressant medication treatment on serum levels of inflammatory cytokines:a Meta-analysis［J］.Neuropsychopharmacology (New York,N.Y.),2011,36(12):2452-2459.
[39] MARQUESDEAK A,NETO F,DOMINGUEZ W,et al.Cytokine profiles in women with different subtypes of major depressive disorder［J］.Journal of Psychiatric Research,2007,41(1-2):152-159.
[40] RUIZ-CASADO A,LVAREZ-BUSTOS A,DE PEDRO CG,et al.Cancer-related fatigue in breast cancer survivors:a review［J］.Clinical Breast Cancer,2021,21(1):10-25.
[41] MAURER T,JASKULSKI S,BEHRENS S,et al.Tired of feeling tired-The role of circulating inflammatory biomarkers and long-term cancer related fatigue in breast cancer survivors［J］.The Breast,2021,56:103-109.
[42] THONG MSY,VAN NOORDEN CJF,STEINDORF K,et al.Cancer-related fatigue:causes and current treatment options［J］.Current Treatment Options in Oncology,2020,21(2):17.
[43] O' HIGGINS CM,BRADY B,O' CONNOR B,et al.The pathophysiology of cancer-related fatigue:current controversies［J］.Supportive Care in Cancer,2018,26(10):3353-3364.
[44] XIAO C,MILLER AH,FELGER J,et al.Depressive symptoms and inflammation are independent risk factors of fatigue in breast cancer survivors［J］.Psychological Medicine,2017,47(10):1733-1743.
[45] XIAO C,BEITLER JJ,HIGGINS KA,et al.Fatigue is associated with inflammation in patients with head and neck cancer before and after intensity-modulated radiation therapy［J］.Brain,Behavior,and Immunity,2016,52:145-152.
[46] MCFARLAND DC,SHAFFER K,BREITBART W,et al.C-reactive protein and its association with depression in patients receiving treatment for metastatic lung cancer［J］.Cancer,2019,125(5):779-787.
[47] ZIELINSKI MR,SYSTROM DM,ROSE NR.Fatigue,sleep,and autoimmune and related disorders［J］.Frontiers in Immunology,2019,10:1827.
[48] LANSER L,KINK P,EGGER EM,et al.Inflammation-induced tryptophan breakdown is related with anemia,fatigue,and depression in cancer［J］.Frontiers in Immunology,2020,11:249.
[49] KINK P,EGGER EM,LANSER L,et al.Immune activation and anemia are associated with decreased quality of life in patients with solid tumors［J］.Journal of Clinical Medicine,2020,9(10):3248.
[50] APPELS A.Inflammation and the mental state before an acute coronary event［J］.Annals of Medicine,1999,31:41-44.
[51] CHARALAMBOUS A,BERGER AM,MATTHEWS E,et al.Cancer-related fatigue and sleep deficiency in cancer care continuum:concepts,assessment,clusters,and management［J］.Supportive Care in Cancer,2019,27(7):2747-2753.
[52] SAVARD J,MORIN CM.Insomnia in the context of cancer:a review of a neglected problem［J］.Journal of Clinical Oncology,2001,19(3):895-908.
[53] KRUEGER JM,OBL JR F,FANG J,et al.The role of cytokines in physiological sleep regulation［J］.Annals of the New York Academy of Sciences,2001,933(1):211-221.
[54] TUCKER JA,OSANN K,HSIEH S,et al.Longitudinal changes in sleep:associations with shifts in circulating cytokines and emotional distress in a cancer survivor population［J］.International Journal of Behavioral Medicine,2021,28(1):140-150.
[55] FOX RS,ANCOLI-ISRAEL S,ROESCH SC,et al.Sleep disturbance and cancer-related fatigue symptom cluster in breast cancer patients undergoing chemotherapy［J］.Supportive Care in Cancer,2020,28(2):845-855.
[56] LIU L,RISSLING M,NATARAJAN L,et al.The longitudinal relationship between fatigue and sleep in breast cancer patients undergoing chemotherapy［J］.Sleep,2012,35(2):237-245.
[57] CHO HJ,LAVRETSKY H,OLMSTEAD R,et al.Sleep disturbance and depression recurrence in community-dwelling older adults:a prospective study［J］.The American Journal of Psychiatry,2008,165(12):1543-1550.
[58] HUANG T,LIN C.The Mediating effects of depression on sleep disturbance and fatigue symptom clusters in patients with hepatocellular carcinoma［J］.Cancer Nursing,2009,32(5):398-403.
[59] GEORGE MA,LUSTBERG MB,ORCHARD TS.Psychoneurological symptom cluster in breast cancer:the role of inflammation and diet［J］.Breast Cancer Research and Treatment,2020,184(1):1-9.
[60] MULLER N,SCHWARZ MJ.The immune-mediated alteration of serotonin and glutamate:towards an integrated view of depression［J］.Molecular Psychiatry,2007,12(11):988-1000.
[61] LEONARD B,MAES M.Mechanistic explanations how cell-mediated immune activation,inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression［J］.Neuroscience & Biobehavioral Reviews,2012,36(2):764-785.
[62] EYRE H,BAUNE BT.Neuroplastic changes in depression:A role for the immune system［J］.Psychoneuroendocrinology,2012,37(9):1397-1416.
[63] PACE TWW,MILLER AH.Cytokines and glucocorticoid receptor signaling［J］.Annals of the New York Academy of Sciences,2009,1179(1):86-105.
[64] HU K,SJLANDER A,LU D,et al.Aspirin and other non-steroidal anti-inflammatory drugs and depression,anxiety,and stress-related disorders following a cancer diagnosis:a nationwide register-based cohort study［J］.BMC Medicine,2020,18(1):238.
[65] KOPF M,BACHMANN MF,MARSLAND BJ.Averting inflammation by targeting the cytokine environment［J］.Nature Reviews Drug Discovery,2010,9(9):703-718.